Research Article

Malondialdehyde and Uric Acid as Predictors of Adverse Outcome in Patients with Chronic Heart Failure

Figure 4

The Kaplan-Meier probability of combined endpoint-free survival in heart failure patients depending on serum malondialdehyde concentration in one-year follow-up. Significant coefficient for the whole model: .